TFEB and acute kidney injury: These findings suggest that tubular mitochondrial dysfunction in cisplatin-induced AKI is mediated, at least partially, by decreasing TFEB expression, and that upregulation of TFEB expression could be a potential therapeutic target for the alleviation of mitochondrial dysfunction and cisplatin-induced TEC injury.